TIME IN THERAPEUTIC RANGE ≥55% VERSUS <55% ON WARFARIN THERAPY OUTCOMES IN NON-VALVULAR ATRIAL FIBRILLATION PATIENTS

被引：1
|
作者：
An, Jaejin [1 ]
Lang, Daniel [1 ]
Fang, Niu [1 ]
Jazdzewski, Kristin [1 ]
Le, Paul [1 ]
Rashid, Nazia [1 ]
Meissner, Brian [1 ]
Mendes, Robert [1 ]
Dills, Diana [1 ]
Ershoff, Dan [1 ]
Borok, Gerald [1 ]
Bruno, Amanda [1 ]
机构：
[1] Kaiser Permanente So Calif, Downey, CA USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2014年 / 63卷 / 12期
关键词：
D O I：
10.1016/S0735-1097(14)60359-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1143-114
引用
收藏
页码：A359 / A359
页数：1
相关论文
共 50 条
  • [41] Warfarin utilization and stroke risk in patients with chronic non-valvular atrial fibrillation
    Boccuzzi, SJ
    Stephenson, JJ
    Kreilick, CA
    Beaulieu, JF
    Hauch, O
    Kim, J
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 335A - 335A
  • [42] TRENDS AND PREDICTORS OF NOAC VERSUS WARFARIN USE FOR STROKE PREVENTION IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
    Brownell, Kenneth B.
    Sezer, Ahmet
    Jain, Sandeep
    Thoma, Floyd
    Kancharla, Krishna
    Bhonsale, Aditya
    Saba, Samir
    Mulukutla, Suresh
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 518 - 518
  • [43] IMPROVEMENT IN THROMBOEMBOLIC OUTCOMES WITH WARFARIN IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION OVER THE LAST TWO DECADES
    Agarwal, Shikhar
    Hachamovitch, Rory
    Menon, Venu
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E1836 - E1836
  • [44] Age is associated with time in therapeutic range for warfarin therapy in patients with atrial fibrillation
    Marcatto, Leiliane Rodrigues
    Sacilotto, Luciana
    da Costa Darrieux, Francisco Carlos
    Hachul, Denise Tessariol
    Scanavacca, Mauricio Ibrahim
    Krieger, Jose Eduardo
    Pereira, Alexandre Costa
    Junior Lima Santos, Paulo Caleb
    ONCOTARGET, 2016, 7 (34) : 54194 - 54199
  • [45] Patient Factors against Stable Control of Warfarin Therapy for Japanese Non-valvular Atrial Fibrillation Patients
    Tomita, Hideharu
    Kadokami, Toshiaki
    Momii, Hidetoshi
    Kawamura, Natsumi
    Yoshida, Masayoshi
    Inou, Tetsuji
    Fukuizumi, Yutaka
    Usui, Makoto
    Funakoshi, Kouta
    Yamada, Satoshi
    Aomori, Tohru
    Yamamoto, Koujiro
    Uno, Tsukasa
    Ando, Shin-ichi
    THROMBOSIS RESEARCH, 2013, 132 (05) : 537 - 542
  • [46] Optimal intensity of warfarin therapy for prevention or stroke recurrence in elderly patients with non-valvular atrial fibrillation
    Yasaka, M
    Minematsu, K
    Otsubo, R
    Sakata, S
    Yamaguchi, T
    STROKE, 2000, 31 (11) : 2774 - 2774
  • [47] Major Bleeding in Patients with Non-Valvular Atrial Fibrillation: Impact of Time in Therapeutic Range on Contemporary Bleeding Risk Scores
    Marco Proietti
    Keitaro Senoo
    Deirdre A. Lane
    Gregory Y. H. Lip
    Scientific Reports, 6
  • [48] Major Bleeding in Patients with Non-Valvular Atrial Fibrillation: Impact of Time in Therapeutic Range on Contemporary Bleeding Risk Scores
    Proietti, Marco
    Senoo, Keitaro
    Lane, Deirdre A.
    Lip, Gregory Y. H.
    SCIENTIFIC REPORTS, 2016, 6
  • [49] TIME IN THERAPEUTIC RANGE (TTR): ANALYSIS IN A LARGE OBSERVATIONAL COHORT TAKING WARFARIN FOR CHADS2 MEASURED RISK IN NON-VALVULAR ATRIAL FIBRILLATION PATIENTS
    Reges, Orna
    Leibowitz, Morton
    Hoshen, Moshe
    Arnson, Yoav
    Balicer, Ran
    Haim, Moti
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 883 - 883
  • [50] Time in therapeutic range, quality of life and treatment satisfaction of patients on long-term warfarin for non-valvular atrial fibrillation: a cross-sectional study
    Ng, Diana-Leh-Ching
    Malik, Natasya Marliana Bt Abdul
    Chai, Chee-Shee
    Goh, Greta-Miranda-Kim-Choo
    Tan, Seng-Beng
    Bee, Ping-Chong
    Gan, Gin-Gin
    Said, Asri B.
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2020, 18 (01)
12345